Macrogen Inc. | Balance Sheet

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Cash & Short Term Investments
43,667
46,416
45,829
59,067
83,639
Total Accounts Receivable
12,452
18,036
24,864
21,101
23,946
Inventories
3,630
6,782
12,191
14,421
15,779
Other Current Assets
870
612
929
1,981
2,015
Total Current Assets
60,619
71,847
83,814
96,571
125,379
Net Property, Plant & Equipment
24,117
39,287
38,871
43,331
40,527
Total Investments and Advances
1,995
4,728
9,233
15,809
6,595
Long-Term Note Receivable
332
158
87
84
612
Intangible Assets
83
159
574
487
687
Other Assets
565
-
-
1,713
2,004
Total Assets
87,712
116,179
136,310
159,523
177,383
ST Debt & Current Portion LT Debt
12,762
-
343
29,732
29,767
Accounts Payable
1,827
4,265
4,875
6,310
6,275
Income Tax Payable
2
109
800
941
4,711
Other Current Liabilities
10,311
12,496
18,745
27,218
30,721
Total Current Liabilities
24,902
16,869
24,763
64,201
71,473
Long-Term Debt
188
30,201
29,452
9,067
10,311
Provision for Risks & Charges
1,200
1,712
1,539
1,061
577
Deferred Taxes
-
-
1,733
1,529
1,579
Other Liabilities
1,375
1,109
1,104
1,327
1,484
Total Liabilities
27,665
49,891
58,857
75,656
83,845
Common Equity (Total)
59,785
66,006
76,113
82,551
92,414
Total Shareholders' Equity
59,785
66,006
76,113
82,551
92,414
Total Equity
60,047
66,287
77,453
83,868
93,538
Liabilities & Shareholders' Equity
87,712
116,179
136,310
159,523
177,383
Accumulated Minority Interest
262
281
1,340
1,317
1,123

About Macrogen

View Profile
Address
10/F, World Meridian Venture Center
Seoul SL 08511
Korea, Republic Of
Employees -
Website http://www.macrogen.co.kr
Updated 09/14/2018
Macrogen, Inc. engages in the provision genetic research and biotechnology services. It services include genome sequencing, oligonucleotide, microarray, genetically engineered mouse, and clinical sequencing. The company was founded on June 5, 1997 and is headquartered in Seoul, South Korea.